Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Maintenance Period (26 Weeks)	STARTED	Sulodexide	524
Maintenance Period (26 Weeks)	STARTED	Placebo	532
Maintenance Period (26 Weeks)	Valid Albumin Creatinine Ratio	Sulodexide	492
Maintenance Period (26 Weeks)	Valid Albumin Creatinine Ratio	Placebo	494
Maintenance Period (26 Weeks)	COMPLETED	Sulodexide	500
Maintenance Period (26 Weeks)	COMPLETED	Placebo	502
Maintenance Period (26 Weeks)	NOT COMPLETED	Sulodexide	24
Maintenance Period (26 Weeks)	NOT COMPLETED	Placebo	30
Washout Period (8 Weeks)	STARTED	Sulodexide	500
Washout Period (8 Weeks)	STARTED	Placebo	502
Washout Period (8 Weeks)	COMPLETED	Sulodexide	494
Washout Period (8 Weeks)	COMPLETED	Placebo	490
Washout Period (8 Weeks)	NOT COMPLETED	Sulodexide	6
Washout Period (8 Weeks)	NOT COMPLETED	Placebo	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00130208/flow